Sort
21,453 grants matching “tuberculosis”
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$506,940Ann R Falsey · University Of Rochester · UM1 · FY2022 · AI
The physiological activation and consequences of Toxin-Antitoxin systems in Salmonella
$506,934Sophie Helaine · Harvard Medical School · R01 · FY2021 · AI
Computational systems immunology core
$506,841Soumya Raychaudhuri · Brigham And Women'S Hospital · P01 · FY2025 · AI
Antigen-specific CD8+ T cells and protective immunity to tuberculosis
$506,783Samuel M Behar · Brigham And Women'S Hospital · R56 · FY2012 · AI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
$506,563John R. Chan · Albert Einstein College Of Medicine · R01 · FY2021 · AI
US BRAZIL COLLABORATION ON IMMUNITY AND BIOMARKERS IN TUBERCULOSIS
$506,339Jerrold J. Ellner · Boston Medical Center · U01 · FY2010 · AI
Medicinal Chemistry Core
$506,270Joel Stephen Freundlich · Rbhs-New Jersey Medical School · U19 · FY2014 · AI
Linkage & Retention: A Randomized Trial to Optimize HIV/TB Care in South Africa
$505,951Ingrid Valerie Bassett · Massachusetts General Hospital · R01 · FY2014 · MH
Initiation of the Immune Response to M. tuberculosis
$505,895Joel D. Ernst · New York University School Of Medicine · R01 · FY2014 · AI
Etiology of Persistent Microalbuminuria in Nigeria
$505,846William Wester · Vanderbilt University Medical Center · R01 · FY2024 · DK
DIRECTLY OBSERVED ANTI RETROVIRAL THERAPY AMONG ACTIVE D
$505,699Yale University · R01 · FY2001 · DA
Testing Novel Interventions to Protect Workers from Airborne Infections
$505,603Edward A. Nardell · Brigham And Women'S Hospital · R01 · FY2013 · OH
Impact of malnutrition on TB-IRIS and pharmacokinetics of TB and ARV co-treatment
$505,545Annelies Van Rie · Univ Of North Carolina Chapel Hill · R01 · FY2011 · HD
Drug Discovery for Fatty Acid Synthase in Oncology
$505,254Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2011 · CA
JHU- Optimal regimen development on a Ribosome inhibitor backbone.
$505,143Eric L Nuermberger · Global Alliance For Tb Drug Development · U19 · FY2020 · AI
Identify the host genetic determinants of immune response and TB countrol
$505,084Ildiko Vanrhijn · Brigham And Women'S Hospital · U19 · FY2020 · AI
Innate Determinants of Microbial Immunity
$505,001Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Mechanisms of increased susceptibility to TB in HIV-Infected individuals
$504,771David H Canaday · Case Western Reserve University · R01 · FY2013 · AI
Active_Case_Finding_Testing_and_Linkage_to_Treatment_and_Improved_Survival_(ACTTIS)_Study
$504,670Neil A Martinson · Wits Health Consortium (Pty), Ltd · R01 · FY2021 · AI
Project 2 - TB Translation as a Target
$504,514James C Sacchettini · Texas A&M Agrilife Research · P01 · FY2020 · AI
Hair Cell Responses to Ototoxic Drugs
$504,479Peter S Steyger · Creighton University · R01 · FY2020 · DC
DRUG DESIGN FOR TREATING OPPORTUNISTIC INFECTION IN AIDS
$504,272University Of Houston · R01 · FY2000 · AI
Microbiome in TB treatment response and disease resolution
$504,019Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2024 · AI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
$503,978John R. Chan · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · AI
A novel protein export chaperone of Mycobacterium tuberculosis
$503,960Miriam S. Braunstein · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI